WESTAIM
Westaim Corporation invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim holds a 75 per cent interest in NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Westaim's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.
WESTAIM
Industry:
Finance Financial Services Venture Capital
Founded:
1996-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.westaim.com
Total Employee:
51+
Status:
Active
Contact:
416-969-3333
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Robert Kittel
Robert Kittel COO @ Westaim COO
Jeffrey Sarfin
Jeffrey Sarfin CFO @ Westaim CFO
J. Cameron MacDonald
J. Cameron MacDonald Prsident & CEO @ Westaim Prsident & CEO
J. Cameron MacDonald
J. Cameron MacDonald CEO/President @ Westaim CEO/President
Stock Details
Company's stock symbol is OTCPINK:WEDXF
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2009-11-10 | NUCRYST Pharmaceuticals | NUCRYST Pharmaceuticals acquired by Westaim | N/A |
Official Site Inspections
http://www.westaim.com
- Host name: cp007.reactivepath.com
- IP address: 38.110.94.40
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...